Barclays’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-11,300
Closed -$2.08M 5363
2020
Q2
$2.08M Sell
11,300
-154,900
-93% -$30.8M ﹤0.01% 2077
2020
Q1
$33.5M Buy
+166,200
New +$32M 0.03% 443
2019
Q3
Sell
-14,300
Closed -$3.6M 6887
2019
Q2
$3.6M Buy
+14,300
New +$3.31M ﹤0.01% 2211
2018
Q3
Sell
-12,100
Closed -$3.55M 7235
2018
Q2
$3.55M Buy
+12,100
New +$3.31M ﹤0.01% 2027

Other funds holding ICUI

Barclays's ICUI Position: Q1 2026 in Review

Barclays reduced its ICU Medical (ICUI) stake by 88% in Q1 2026, selling an estimated $4.75M and leaving 4,636 shares worth $599K. The position accounts for ﹤0.01% of the portfolio, ranked #3079.

Barclays first reported a position in ICUI in Q2 2013 and has held it in 50 quarters since. The position peaked at $34.5M in Q3 2021. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Barclays held 4,636 shares of ICU Medical worth $599K as of Q1 2026.
  • Barclays sold 33,069 ICU Medical shares in Q1 2026, an estimated $4.75M.
  • ICU Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3079 holding.
  • Barclays first reported a position in ICU Medical in Q2 2013 and has held it in 50 quarters since.
  • Barclays's ICU Medical position peaked at $34.5M in Q3 2021.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.